tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Crinetics Pharmaceuticals Inc

CRNX
Add to Watchlist
83.865USD
+0.135+0.16%
Close 07-27 16:00（ET）Quotes delayed by 15 min
8.83BMarket Cap
LossP/E TTM

Crinetics Pharmaceuticals Inc

83.865
+0.135+0.16%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

CRNX Financials

See Crinetics Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Crinetics Pharmaceuticals Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/-1.21
Revenue / Forecast
--/14.84M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
7.70M
640.71%
EPS(YoY)
-4.95
-33.93%
Analyst Rating
HOLD
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-18.15%-1.23
-46.79%-1.29
-43.94%-1.38
-31.54%-1.23
-12.27%-1.04
1.52%-0.88
5.16%-0.96
0.21%-0.94
-8.52%-0.93
-6.94%-0.89
---1.01
---0.94
---0.85
---0.84
---2.32
----
----
----
----
----
Revenue
2873.41%10.73M
--6.16M
--143.00K
158.40%1.03M
-43.59%361.00K
--0.00
-100.00%0.00
-59.62%399.00K
-76.11%640.00K
-100.00%0.00
-24.45%346.00K
125.06%988.00K
-14.44%2.68M
-34.23%709.00K
--458.00K
--439.00K
--3.13M
--1.08M
--0.00
--0.00
Net Profit
-32.11%-127.84M
-52.39%-122.81M
-69.33%-130.09M
-56.15%-115.64M
-44.59%-96.77M
-34.11%-80.59M
-33.71%-76.83M
-45.27%-74.06M
-45.52%-66.93M
-33.58%-60.10M
-37.05%-57.46M
-20.30%-50.98M
-32.83%-45.99M
-46.10%-44.99M
-50.53%-41.92M
-62.39%-42.38M
-51.20%-34.63M
-42.29%-30.79M
-52.03%-27.85M
-58.24%-26.09M
Net Margin
95.56%-1191.03%
---1993.43%
---90972.73%
39.57%-11216.00%
-156.34%-26807.20%
----
----
-259.71%-18560.15%
-509.12%-10457.81%
----
---16606.36%
---5159.82%
---1716.87%
---6345.70%
---2952.51%
----
----
----
----
----
Gross Margin
-1.86%98.14%
--82.54%
--100.00%
0.00%100.00%
0.00%100.00%
----
----
0.00%100.00%
0.00%100.00%
----
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Income Statement
Revenue
2873.41%10.73M
--6.16M
--143.00K
158.40%1.03M
-43.59%361.00K
--0.00
-100.00%0.00
-59.62%399.00K
-76.11%640.00K
-100.00%0.00
-24.45%346.00K
125.06%988.00K
-14.44%2.68M
-34.23%709.00K
--458.00K
--439.00K
--3.13M
--1.08M
--0.00
--0.00
Operating profit
-26.01%-140.38M
-41.08%-133.67M
-62.40%-142.59M
-55.96%-129.11M
-51.51%-111.41M
-51.21%-94.75M
-48.87%-87.80M
-56.21%-82.78M
-53.26%-73.53M
-31.76%-62.66M
-35.72%-58.98M
-23.12%-52.99M
-41.83%-47.98M
-53.96%-47.56M
-56.27%-43.45M
-64.99%-43.05M
-47.60%-33.83M
-41.75%-30.89M
-50.71%-27.81M
-54.11%-26.09M
Net Profit
-32.11%-127.84M
-52.39%-122.81M
-69.33%-130.09M
-56.15%-115.64M
-44.59%-96.77M
-34.11%-80.59M
-33.71%-76.83M
-45.27%-74.06M
-45.52%-66.93M
-33.58%-60.10M
-37.05%-57.46M
-20.30%-50.98M
-32.83%-45.99M
-46.10%-44.99M
-50.53%-41.92M
-62.39%-42.38M
-51.20%-34.63M
-42.29%-30.79M
-52.03%-27.85M
-58.24%-26.09M
Balance Sheet
Current assets
2.43%1.32B
-23.78%1.05B
27.77%1.12B
39.15%1.22B
40.76%1.29B
139.55%1.38B
52.42%877.59M
207.14%874.78M
200.33%917.23M
66.33%574.15M
52.19%575.76M
-31.58%284.81M
-6.96%305.40M
0.13%345.18M
85.48%378.32M
96.96%416.29M
108.01%328.25M
94.22%344.72M
5.07%203.97M
0.35%211.35M
Total current liabilities
24.04%71.09M
42.54%85.07M
38.45%74.16M
25.78%68.40M
10.71%57.31M
35.82%59.68M
32.37%53.56M
66.75%54.38M
96.68%51.77M
58.50%43.94M
64.78%40.46M
24.87%32.61M
29.94%26.32M
73.32%27.72M
97.40%24.56M
119.10%26.11M
97.36%20.26M
52.49%15.99M
40.84%12.44M
20.76%11.92M
Total assets
2.94%1.40B
-21.49%1.13B
27.59%1.20B
37.84%1.29B
39.17%1.36B
125.79%1.43B
46.11%937.37M
219.02%935.53M
211.50%978.15M
80.41%635.35M
66.68%641.54M
-30.46%293.25M
-5.78%314.01M
0.33%352.18M
83.84%384.88M
94.41%421.73M
103.78%333.29M
91.35%351.01M
4.51%209.36M
-0.09%216.93M
Total liabilities
12.44%120.68M
22.21%134.17M
18.65%123.86M
12.67%118.05M
3.98%107.33M
14.07%109.79M
11.31%104.39M
167.70%104.77M
206.48%103.22M
168.49%96.25M
179.90%93.79M
10.04%39.14M
11.36%33.68M
87.97%35.85M
112.49%33.51M
129.63%35.57M
114.94%30.24M
31.29%19.07M
20.42%15.77M
7.95%15.49M
Total equity
2.12%1.28B
-25.11%992.08M
28.71%1.07B
41.02%1.17B
43.33%1.25B
145.74%1.32B
52.07%832.98M
226.92%830.76M
212.11%874.93M
70.43%539.11M
55.89%547.75M
-34.19%254.12M
-7.50%280.33M
-4.70%316.33M
81.50%351.37M
91.70%386.17M
102.73%303.04M
96.51%331.94M
3.40%193.59M
-0.66%201.44M
Cash Flow Statement
Net operating income
-40.98%-124.70M
-43.65%-92.90M
-76.24%-110.72M
-88.20%-85.85M
-67.35%-88.45M
-67.92%-64.67M
-51.97%-62.82M
0.26%-45.62M
-29.81%-52.86M
-9.40%-38.52M
-7.43%-41.34M
-63.48%-45.73M
-200.66%-40.72M
-53.75%-35.21M
-49.88%-38.48M
-40.24%-27.98M
32.51%-13.54M
-43.68%-22.90M
-42.60%-25.67M
-25.82%-19.95M
Net investment
-193.57%-252.36M
110.53%57.11M
699.93%164.81M
170.75%37.95M
-27919.09%-85.96M
-520.89%-542.09M
110.66%20.60M
-270.64%-53.64M
-99.37%309.00K
-336.91%-87.31M
-2933.42%-193.30M
118.04%31.44M
212.38%48.76M
136.20%36.85M
197.11%6.82M
-978.47%-174.27M
-233.48%-43.38M
-1044.83%-101.80M
71.71%-7.03M
12.70%19.84M
Net financing
8686.91%389.88M
-95.30%26.04M
-94.62%3.08M
28.37%7.05M
-98.87%4.44M
1360.88%554.04M
-83.03%57.33M
-56.58%5.50M
81216.94%393.57M
32878.26%37.92M
31301.21%337.88M
-89.36%12.66M
-72.81%484.00K
-99.93%115.00K
-93.04%1.08M
62.33%118.99M
3022.81%1.78M
168823.71%163.86M
9886.71%15.46M
-32.22%73.30M

FAQs

What is the total revenue of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 7.70M, with a year-on-year change of 1.04M.

What are the current assets of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its current assets were 1.05B, with a year-on-year change of -23.78.

What are the total assets of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its total assets of Crinetics Pharmaceuticals Inc were 1.13B, with a year-on-year change of -21.49.

What are the total liabilities of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Crinetics Pharmaceuticals Inc were 134.17M, with a year-on-year change of 22.21.

What is the total equity of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its total equity of Crinetics Pharmaceuticals Inc was 992.08M, with a year-on-year change of -25.11.

What is the net operating income of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Crinetics Pharmaceuticals Inc was -516.77M, with a year-on-year change of -52.50.

What is the net investment of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its net investment of Crinetics Pharmaceuticals Inc was 173.91M, with a year-on-year change of 130.25.

What is the net financing of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its net financing of Crinetics Pharmaceuticals Inc was 40.61M, with a year-on-year change of -96.00.

What is the Earnings Per Share (EPS) of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.95, with a year-on-year change of -33.93.

What is the net income of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its net income was -465.32M, with a year-on-year change of -55.93.

What is the net margin of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -6046.22, with a year-on-year change of 78.95.

What is the gross margin of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 86.02, with a year-on-year change of -13.98.

What is the Return on Equity (ROE) of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -40.17, with a year-on-year change of -25.45.

What is the Return on Assets (ROA) of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -36.34, with a year-on-year change of -26.04.

What is the operating profit of Crinetics Pharmaceuticals Inc?

According to Crinetics Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -516.77M, with a year-on-year change of -52.50.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy